Literature DB >> 4195358

Emetine myopathy.

D D Duane, A G Engel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4195358     DOI： 10.1212/wnl.20.8.733

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  8 in total

1.  Myopathy from surreptitious ipecac ingestion.

Authors:  N L Rosenberg; S P Ringel
Journal:  West J Med       Date:  1986-09

Review 2.  Adverse effects of drugs on muscle.

Authors:  F L Mastaglia
Journal:  Drugs       Date:  1982-10       Impact factor: 9.546

3.  Experimental emetine myopathy: enzyme histochemical, electron microscopic, and immunomorphological studies.

Authors:  N J Hopf; H H Goebel
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

4.  Ultrastructural pathology in emetine-induced myopathy.

Authors:  L Halbig; L Gutmann; H H Goebel; J F Brick; S Schochet
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

5.  Ultrastructural alterations in skeletal muscle of pigs with acute monensin myotoxicosis.

Authors:  J F Van Vleet; V J Ferrans
Journal:  Am J Pathol       Date:  1984-03       Impact factor: 4.307

6.  Emetine myopathy in the rat.

Authors:  W G Bradley; J D Fewings; J B Harris; M A Johnson
Journal:  Br J Pharmacol       Date:  1976-05       Impact factor: 8.739

7.  Lesions of the myofibril in myopathic and normal tissue from seven striated muscles. Experimental myopathy of isometric activity produced by phencyclidine and restraint.

Authors:  R W Kuncl; H Y Meltzer
Journal:  Acta Neuropathol       Date:  1979-02-15       Impact factor: 17.088

8.  Reversible emetine-induced myopathy with ECG abnormalities: a toxic myopathy.

Authors:  T Kuntzer; J Bogousslavsky; J P Deruaz; R Janzer; F Regli
Journal:  J Neurol       Date:  1989-05       Impact factor: 4.849
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.